Cylert

Lea en español

CylertCylert is the brand name for Pemoline, a stimulant first synthesized in 1913 and used to treat ADHD (attention deficit hyperactivity disorder) and narcolepsy. Pemoline has been pulled from the U.S. market because of reports connecting its use in children to increased risk of liver failure. After the U.S. Food and Drug Administration (FDA) issued a warning not to prescribe Pemoline for ADHD, the manufacturer and patent owner (Abbott Laboratories) stopped making Cylert.

Pemoline was first approved by the FDA in 1975. Since that date, more than 20 liver failures have been linked to the drug. Pemoline is believed to cause hepatoxicity, a chemically induced form of liver damage.

If you or someone you love has used any type of Cylert and experienced detrimental side effects, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.

Defective Drugs & Medical Devices Topics

Latest Articles

Happy Veterans Day 2019

“Honoring the sacrifices many have made for our country in the name of freedom and democracy i…

Read More 08 Nov 2019, Friday

Deficiency Judgment and Foreclosures

A person borrowing money to buy a home assumes the loan is secured by the mortgage lien on the house…

Read More 07 Nov 2019, Thursday

How Can a Lawyer Help You Defend Against Foreclosure?

If you fall behind on your mortgage payments, your house might end up in foreclosure. However, there…

Read More 21 Oct 2019, Monday